Everything you need to know about China’s Patent Term Extension (PTE)
By Hongyue Li | Posted on March 10, 2026
The pharmaceutical field is one that relies most heavily on patent protection. The development of new drugs involves high costs, long cycles, and significant risks. Without patent protection, new drug R&D enterprises would find it difficult to recoup R&D costs and earn reasonable profits, thereby reducing their incentive to develop new drugs. Meanwhile, due to...
Inventor information requirements in the amended Chinese Patent Examination Guidelines
By Hongyue Li | Posted on January 6, 2026
The China National Intellectual Property Administration (CNIPA) announced the latest revisions to the Patent Examination Guidelines on November 10, 2025, which came into effect on January 1, 2026. Among the revisions, the updated requirements for filing all inventors’ information in patent applications have garnered widespread attention across the industry. This update clarifies the modification to the inventor...
Recent contributors
Senior Associate, China Patent Attorney
Associate, Attorney at Law
Counsel, European Patent Attorney
Partner, Attorney at Law, Business Area Manager
Partner, European Patent Attorney
Senior Counsel, European Patent Attorney